Emcure Pharmaceuticals IPO booked nearly 3x so far on Day 2. Check GMP and other details

Emcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on July 5. The categories allocated for Non-Institutional Investors (NII) and retail investors saw the highest demand, with subscriptions reaching 7.5 times and 2.6 times, respectively.